News and Breakthroughs
Read the latest news from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The links below take you to articles where you can learn more about our center's latest events and accomplishments. You can also visit the article archive for older news. Visit our Photo Gallery to view photos and videos from various events
Men with advanced prostate cancer who were treated based on the genetic makeup of their cancer survived significantly longer than those treated with standard treatments, according to a new study.
Sheetal Kircher, MD, Medical Director of the Cancer Survivorship Institute at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, was named an Advocacy Champion by the Association for Clinical Oncology (ASCO) during the association’s 2020 Advocacy Summit on September 16
Inhibiting an epigenetic regulator called DOT1L could be a key to slowing treatment-resistant prostate cancer, according to a recent Northwestern Medicine study.
Biomarkers using mass cytometry can assess patient response to an emerging treatment for pediatric brain tumors, according to a recent multi-center study.
On June 7, not even a worldwide pandemic could prevent hope, love, and support from flourishing in the fight against cancer. Celebrating together while safely apart, the 27th Annual Cancer Survivors’ Celebration Walk & 5K, hosted by the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, pivoted quickly to become a virtual event to applaud cancer survivors and all those who support them.
A new combination therapy targeting breast cancer tumors in the brain dramatically decreased tumor size and increased survival in mice, according to a new study.
Daniela Matei, MD, Diana, Princess of Wales Professor of Cancer Research at Northwestern Feinberg School of Medicine, Chicago, grew up Sibiu, a picturesque Romanian city situated at the foothills of the Cindrel Mountains in historic Transylvania. “Both of my parents were physicians, and some of my early passion for science was ignited by their professions. But as a child, I didn’t want to pursue a career as a doctor; my dream was to become a writer.”
Sarki Abdulkadir, MD, PhD, has been named the winner of the 2020 Tripartite Legacy Faculty Prize in Translational Science and Education for his work investigating the molecular pathways that drive prostate cancer.
Genomic alterations in prostate cancer therapeutic targets were found to be similar between African American and European American men, suggesting that existing precision medicine approaches could equally benefit both groups if applied equitably, according to a recent study.
Iron nanoparticles could be one day used to attack cancer cells, according to a recent Northwestern Medicine study.
A machine-learning program called Peakachu can reveal previously unknown chromatin loops, according to a Northwestern Medicine study published in Nature Communications.
Only about 5% of doctors are African American. A neurosurgeon in training shows Adriana Diaz how difficult it can be for doctors of color to overcome barriers and how diversity can help improve care.
Measuring epigenetic signatures in blood plasma could help classify brain tumors, according to a study published in Nature Medicine.
Lurie Cancer Center is pleased to announce that Adam Lin, MD, PhD, has been selected by the American Society of Hematology (ASH) to participate in the 2020 ASH Clinical Research Training Institute (CRTI).
My cancer journey began when I was diagnosed with a stage 3/4 (Synovial/soft tissue) sarcoma in 2013 at age 23.
- Lurie Cancer Center at Northwestern Memorial Hospital Ranked #8 in the Nation by U.S. News & World Report07.28.2020
The Lurie Cancer Center at Northwestern Memorial Hospital is ranked #8 in the nation by U.S. News & World Report in its 2020-2021 list of Best Hospitals for Cancer. Lurie Cancer Center is also recognized once again as the #1 cancer program in Illinois and Chicago.
A specific cell signaling protein may be used to enhance the sensitivity of medulloblastoma tumors to immunotherapy, potentially improving quality of life for patients with the malignant pediatric brain cancer.
Northwestern Medicine investigators have discovered that the growth of cancerous tumors requires the activation of a specific biochemical process within the mitochondria of tumor cells, showing potential as a new target for cancer therapy.
An emerging cancer treatment also helps prevent cells from turning into viral factories by interfering with HIV infection processes inside the cell, according to a recent study.
Losing weight during COVID-19 pandemic is urgent as obesity increases risk of severe disease and death
See more news in the article archive.